Glimewise-M 1 Tablet PR
Marketer
Medwise Overseas Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimewise-M 1 Tablet PR
Diabetol Duo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for managing type 2 diabetes in adults. This formulation helps regulate blood glucose. Diabetol Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's a component of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular mealtimes and carry a quick-acting glucose source, like sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Other potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Its suitability for pregnant or breastfeeding individuals requires medical consultation. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, will be necessary.
Uses of Glimewise-M 1 Tablet PR
Managing type 2 diabetes
Major Benefits of Glimewise-M 1 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidelines. Take one Glimewise-M PR tablet with food.
Common Side effects of Glimewise-M 1 Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimewise-M 1 Tablet PR:
Follow your physician's instructions or consult the product label for usage guidelines. Administer one Glimewise-M tablet (PR) with a meal.
How Glimewise-M 1 Tablet PR works:
Glimewise-M PR, a single-tablet formulation, unites the antidiabetic actions of glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts triply: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Glimewise-M 1 Tablet PR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimewise-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should not use Glimewise-M 1 Tablet PR; evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with impaired kidney function should use Glimewise-M 1 Tablet PR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Glimewise-M 1 Tablet PR is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimewise-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate hepatic dysfunction, initiation with a reduced dose is typical; however, Glimewise-M 1 Tablet PR is contraindicated in patients with severe liver disease.
What if you forget to take Glimewise-M 1 Tablet PR :
For a missed Glimewise-M 1 Tablet PR dose, take it promptly unless your next dose is imminent. In that case, omit the missed dose and resume your usual medication schedule. Avoid taking a double dose.
Facts to Know About Glimewise-M 1 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |



